[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Mitigation](https://github.com/mm80843/T3.5/tree/main/docs/Mitigation/index.md) >> Individual ID:PBN__Mitigation_1621 

# __Conduct more research and studies to gather sufficient evidence on the effectiveness of upper-room uvgi against sars-cov-2__

## Category to which it belongs

* [Promote self-cleaning spaces, implement touchless technologies, and use natural light to establish safer environments.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_80.md)

## Closest similar item

* [Conduct research on the key factors contributing to the transmission of sars-cov-2.](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_3061.md)
* [Continue research and development of vaccines against sars-cov-2.](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_3062.md)
* [Regular testing and evaluation of the effectiveness of portable air filters in reducing sars-cov-2 transmission](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_2834.md)
* [Development and implementation of standardized protocols and assays for sars-cov-2 detection in environmental samples can ensure consistency and comparability of data.](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_2164.md)
* [Use uvgi systems in air ventilation systems](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_1641.md)
* [Anti-sars-cov-2 coating](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_3345.md)
* [Conduct further research and studies to determine the effectiveness of uvgi systems in preventing healthcare-associated infections](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_2328.md)
* [Validate and optimize pcr assays to ensure accurate detection of sars-cov-2 genetic material.](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_3038.md)
* [Development and implementation of validated methodological protocols for the quantitative analysis of sars-cov-2 in wastewater.](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_1600.md)
* [Consider alternative infection control technologies, such as laminar airflow, before using uvgi systems in operating rooms](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_2325.md)

## Risks possibly mitigated by this Mitigation

* [Insufficient evidence of uv-c effectiveness against sars-cov-2](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1165.md)

